The latest edition of the GIST and Sarcoma Journal is now available online. The GIST and Sarcoma Journal is a comprehensive and authoritative resource for scientifically valid information for physicians, allied healthcare professionals and the patient community regarding advances in the diagnosis and treatment of gastrointestinal stromal tumors and other sarcomas. In the latest issue, […]
Dr. Jonathan Trent, GIST and Sarcoma Journal, GIST Education, GIST research, liquid biopsy, National Leiomyosarcoma Foundation, New York Presbyterian/Columbia University Medical Center, SarcomaA significant finding from a newly published study in JAMA Oncology, indicates that nearly one-fourth of GIST patients with advanced disease initially treated with imatinib will survive for ten years or more. The study, a follow-up of a randomized clinical trial of 695 adult GIST patients, was coordinated by SWOG, with participation from member and […]
Clinical Trial, Dr. Michael Heinrich, GIST research, Gleevec, imatinib, JAMA Oncology, KIT exon 11, research, SWOG
The Life Raft Group presented an informative webcast on Gene Fusions. Presented on February 22, 2017 Learn about: Recently identified gene fusions in GIST Populations they target Current studies that may identify them How they can be used to guide therapeutic decision making. About the presenter Dr. Sicklick is the Associate Professor of Surgery at Moores Cancer […]
Collaboration Lays the Groundwork for Breakthrough in GIST By Brielle Urciuoli This article originally appeared in the January 30th edition of Cure Today. Less than two decades ago, Gleevec (imatinib) drastically changed the frontline treatment for patients with gastrointestinal stromal tumors (GIST). However, as patients develop resistance to Gleevec, as well as second and third […]
Brielle Urciuoli, Cure Today, Dr. Gary Schwartz, GIST Collaborative Tissue Bank, GIST research, LRG Patient Registry, New York Presbyterian/Columbia University Medical Center, Norman Scherzer